Gilead Sciences (GILD) Change in Acquisitions & Divestments (2009 - 2026)

Gilead Sciences (GILD) has reported Change in Acquisitions & Divestments for 18 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Acquisitions & Divestments rose 247.12% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $4.1 billion (up 1290.85% YoY), and the FY2025 full-year result was $854.0 million, down 62.3% from the prior year.
• Change in Acquisitions & Divestments declined to $1.0 billion in Q2 2026 per GILD's latest filing, from $2.5 billion in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $2.5 billion in Q1 2026 and bottomed at $219.0 million in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $684.8 million across 5 years, with a median of $353.5 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments plunged 50.36% in 2022, then surged 599.07% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $358.0 million in 2022, then fell by 2.51% to $349.0 million in 2023, then soared by 549.0% to $2.3 billion in 2024, then plunged by 84.99% to $340.0 million in 2025, then soared by 201.18% to $1.0 billion in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.0 billion, $2.5 billion, and $340.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.